Is NCT06864338 recruiting in Morrisville, NC?

Yes, NCT06864338 is currently recruiting participants at its Morrisville, NC location. This colorectal cancer screening clinical trial is actively enrolling qualified participants.

How do I join the colorectal cancer screening clinical trial in Morrisville?

To join this clinical trial in Morrisville, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Morrisville clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Colorectal Cancer Screening Clinical Trial in Morrisville, NC

Who Can Participate

Inclusion Criteria

Subject is any sex and ≥45 years of age

Subject must be advised to have or be scheduled for a screening colonoscopy

Subject is at average risk for colorectal cancer according to the United States Preventive Services Task Force (USPSTF) guidelines, including:

no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory bowel disease

no family history of colorectal cancer (defined as one or more first degree relatives including parent, sibling, or child)

no personal diagnosis or family history of known genetic disorders that predispose them to a high lifetime risk of colorectal cancer including:

Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease

Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP)

Hereditary non-polyposis colorectal cancer syndrome (also referred to as "HNPCC" or "Lynch Syndrome")

Other hereditary cancer syndromes including but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Gardner's Syndrome, Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis and Familial Hyperplastic Polyposis

Cronkhite Canada Syndrome

Subject can understand the study procedures, and is able to provide consent to participate in the study and authorizes release of relevant protected health information through reviewing and consenting to a Health Insurance Portability and Accountability Act (HIPAA) medical release form

Subject is able and willing to provide stool samples within ninety (90) days before the colonoscopy procedure

Subject is able and willing to undergo a colonoscopy after providing a stool sample

Exclusion Criteria

1\. Subject had any precancerous findings on most recent colonoscopy. This does not include non-neoplastic polyps and/or hyperplastic polyps of any size (Note: tissue biopsies that result in no histopathology findings are acceptable) 2. Subject has a history of abnormal imaging suggesting colorectal cancer (e.g., colonography, MRI, CT, barium enema) 3. Subject has a history of any of the following cancers: oral, head and neck, lung, esophagus, gastric, biliary/liver, pancreatic, small bowel, or appendiceal 4. Subject has had a positive non-invasive screening diagnostic within the associated recommended intervals

High-sensitivity fecal occult blood test or fecal immunochemical test within the previous twelve (12) months

sDNA-FIT test within the previous thirty-six (36) months 5. Subject has had a colonoscopy in the previous nine (9) years (not including failed/ aborted colonoscopy e.g., due to failed preparation, inability to reach the cecum, patient instability during the procedure, etc.) 6. Subject has had a prior colorectal resection for any reason other than sigmoid diverticular disease 7. Indication for colonoscopy due to overt rectal bleeding (e.g., hematochezia or melena) within the previous thirty (30) days (Note: blood on toilet paper, after wiping, does not constitute rectal bleeding) 8. Subject has any condition that in the opinion of the investigator should preclude participation in the study Group 2: Diagnostic Group Inclusion Criteria

Subject is any sex and ≥ 18 years of age

Subject is able and willing to give informed consent

Through imaging, a positive non-invasive screening test, or colonoscopy requiring additional intervention subject is suspected or known to have Colorectal Cancer or Advanced Adenoma

Subject has not yet been treated (e.g., ablation, surgical resection, radiation, chemotherapy, etc.) and still has at least one intact or partially intact lesion

Subject must have a diagnostic colonoscopy or surgical intervention scheduled within 90 days of sample collection

Subject can understand the study procedures and is able to provide consent to participate in the study and authorizes release of relevant protected health information through reviewing and consenting to a Health Insurance Portability and Accountability Act (HIPAA) medical release form

Subject is able and willing to provide stool samples within ninety (90) days of enrollment and before any treatment procedures are initiated Exclusion Criteria 1\. Subject has had a tumor or malignancy other than colorectal cancer identified within the past five years (does not include non-melanoma skin cancer) 2. Subject has been previously diagnosed with inflammatory bowel disease (ulcerative colitis or Crohn's disease) 3. Subject has any condition that in the opinion of the investigator should preclude participation in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Morrisville?

Yes, this clinical trial (NCT06864338) has an active research site in Morrisville, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Cancer Screening Treatment Options in Morrisville, NC

If you're searching for colorectal cancer screening treatment options in Morrisville, NC, this clinical trial (NCT06864338) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Morrisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer screening specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal cancer screening clinical trials near you to find additional studies recruiting in your area.

Colorectal Cancer Screening Clinical Trial in Morrisville, NC

Expert Care in Morrisville

IRB Approved

No-Cost Care

Apply for This Morrisville Location

Why Participate?

Simple Process

About This Colorectal Cancer Screening Study in Morrisville